← All Mink Therapeutics, INC filings

Mink Therapeutics, INC Form 4 insider transactions

NASDAQ
INKT
Mink Therapeutics, INC
Form 4: MiNK Therapeutics Director Barbara Ryan Reports Acquisition and Disposal of Common Stock
Director Barbara Ryan reported acquiring 18,685 shares of MiNK Therapeutics common stock at $0.95 per share and disposing of 86,617 shares on March 1, 2024.
NASDAQ
INKT
Mink Therapeutics, INC
Form 4: Mink Therapeutics Director Ulf Wiinberg Acquires Shares and Holds RSUs
Director Ulf Wiinberg reports acquisition of Mink Therapeutics shares and holding of restricted stock units (RSUs) in a recent SEC filing.
NASDAQ
INKT
Mink Therapeutics, INC
Form 4: Mink Therapeutics Director Brian Corvese Acquires Shares in Lieu of Cash Compensation
Director Brian Corvese acquired 18,816 shares of Mink Therapeutics common stock at $0.95 per share in lieu of cash retainers for board and committee compensation.